Company Filing History:
Years Active: 2004-2008
Title: Iain Andrew Sharpe: Innovator in Peptide Research
Introduction
Iain Andrew Sharpe is a notable inventor based in Taringa, Australia. He has made significant contributions to the field of peptide research, holding a total of 3 patents. His work focuses on the development of novel peptides with therapeutic applications.
Latest Patents
One of his latest patents involves conotoxin peptides. This invention relates to an isolated, synthetic, or recombinant α-conotoxin peptide that has the ability to inhibit a neuronal amine transporter. It also includes nucleic acid molecules encoding all or part of such peptides, antibodies to these peptides, and methods of treatment involving them. Another significant patent pertains to novel peptides and derivatives that serve as selective α1-adrenoceptor antagonists. These peptides exhibit a greater ability to inhibit the agonist action of noradrenaline on the α1-adrenoceptor compared to their action on other α-adrenoceptors. This invention also encompasses pharmaceutical compositions comprising these peptides.
Career Highlights
Iain has worked with esteemed institutions such as the University of Queensland and Xenome Limited. His research has contributed to advancements in the understanding and application of peptide technology in medicine.
Collaborations
Throughout his career, Iain has collaborated with notable colleagues, including Richard James Lewis and Paul Francis Alewood. These partnerships have further enriched his research endeavors and innovations.
Conclusion
Iain Andrew Sharpe is a distinguished inventor whose work in peptide research has led to valuable patents and collaborations. His contributions continue to impact the field of medicinal chemistry and therapeutic development.